Tenet Healthcare Corp

Chart & Performance

D1W1MN

P/E

19.09

P/S

0.57

EPS

6.43

Div Yield, %

0.00%

Shrs. gr., 5y

0.18%

Rev. gr., 5y

2.33%

Revenues

20.55b

+7.17%

Net income

611m

-38.90%

CFO

2.37b

+119.21%

Dividend

Mar 13, 20000.01 USD/sh

Earnings

Feb 06, 2025

Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

URL

https://www.tenethealth.com/

IPO date

May 22, 1981

Employees

75,776

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	20,548,000 7.17%	19,174,000 -1.60%
Cost of revenue	21,889,000	12,117,000
Unusual Expense (Income)
NOPBT	(1,341,000)	7,057,000
NOPBT Margin		36.81%
Operating Taxes	306,000	344,000
Tax Rate		4.87%
NOPAT	(1,647,000)	6,713,000
Net income	611,000 -38.90%	1,000,000 -32.30%
Dividends
Dividend yield
Proceeds from repurchase of equity	(200,000)	(250,000)
BB yield	2.53%	4.64%
Debt
Debt current	324,000	145,000
Long-term debt	17,016,000	16,145,000
Deferred revenue		13,000
Other long-term liabilities	1,829,000	2,908,000
Net debt	14,218,000	12,285,000
Cash flow
Cash from operating activities	2,374,000	1,083,000
CAPEX	(751,000)	(762,000)
Cash from investing activities	(969,000)	(808,000)
Cash from financing activities	(1,035,000)	(1,781,000)
FCF	(3,215,000)	5,886,000
Balance
Cash	1,228,000	858,000
Long term investments	1,894,000	3,147,000
Excess cash	2,094,600	3,046,300
Stockholders' equity	3,535,000	2,490,000
Invested Capital	21,455,400	20,118,000
ROIC		32.83%
ROCE		30.92%
EV
Common stock shares outstanding	104,800	110,516
Price	75.57 54.89%	48.79 -40.27%
Market cap	7,919,736 46.88%	5,392,076 -39.20%
EV	26,037,736	21,143,076
EBITDA	(471,000)	7,898,000
EV/EBITDA		2.68
Interest	901,000	890,000
Interest/NOPBT		12.61%